Tellado Jose M, Sen Shuvayu S, Caloto M Teresa, Kumar Ritesh N, Nocea Gonzalo
Hospital Gregorio Marañon, Madrid, Spain.
Scand J Infect Dis. 2007;39(11-12):947-55. doi: 10.1080/00365540701449377. Epub 2007 Jun 5.
To assess the association between inappropriate antibiotic therapy and clinical outcomes for complicated community-acquired intra-abdominal infections in Spain, patient records from October 1998 to August 2002 in 24 hospitals were reviewed. Initial empiric therapy was classified appropriate if all isolates were sensitive to at least 1 of the antibiotics administered. Multivariate analyses were performed to assess associations between appropriateness of therapy and patient outcomes. Healthcare resource use was measured as hospital length of stay (LOS) and d on intravenous antibiotic therapy. A total of 425 patients were included. Of these, 387 (91%) received appropriate initial empiric therapy. Patients on inappropriate therapy were less likely to have clinical success (79% vs 26%, p<0.001), more likely to require additional antibiotic therapy (40% vs 7%, p<0.01) and more likely to be re-hospitalized within 30 d of discharge (18% vs 3%, p<0.01). Multivariate analyses also showed that inappropriate therapy was associated with an almost 16% increase in LOS (p<0.05) and 26% in d of intravenous antibiotic therapy compared with appropriate therapy (p<0.05). Inappropriate initial antibiotic therapy was associated with a significantly higher proportion of unsuccessful patient outcomes (including death, re-operation, re-hospitalization or additional parental antibiotic therapies), increased length of stay and length on therapy.
为评估西班牙复杂社区获得性腹腔内感染中不恰当抗生素治疗与临床结局之间的关联,研究人员回顾了1998年10月至2002年8月期间24家医院的患者记录。如果所有分离株对至少一种所使用的抗生素敏感,则初始经验性治疗被分类为恰当。进行多变量分析以评估治疗恰当性与患者结局之间的关联。医疗资源使用以住院时间(LOS)和静脉抗生素治疗天数来衡量。总共纳入了425例患者。其中,387例(91%)接受了恰当的初始经验性治疗。接受不恰当治疗的患者临床成功的可能性较小(79%对26%,p<0.001),更有可能需要额外的抗生素治疗(40%对7%,p<0.01),并且在出院后30天内再次住院的可能性更大(18%对3%,p<0.01)。多变量分析还显示,与恰当治疗相比,不恰当治疗与住院时间增加近16%(p<0.05)和静脉抗生素治疗天数增加26%相关(p<0.05)。不恰当的初始抗生素治疗与患者结局不佳(包括死亡、再次手术、再次住院或额外的肠外抗生素治疗)的比例显著更高、住院时间延长和治疗天数增加相关。